Silvaco Group Inc
For the period ended Jun 30, 2024. Filed Aug 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 7, 2024
SVCO$7.03+4.5%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net (loss) income | $(37,010) | $483 |
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | ||
| Depreciation and amortization | 475 | 309 |
| Stock-based compensation expense | 21,829 | — |
| Provision for credit losses | 143 | 43 |
| Estimated litigation claim | 14,696 | — |
| Loss on debt extinguishment | 718 | — |
| Accretion of discount on marketable securities, net | (194) | — |
| Change in fair value of contingent consideration | (18) | 341 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (3,102) | 759 |
| Contract assets | (4,081) | 290 |
| Prepaid and other current assets | (882) | (13) |
| Other assets | (84) | — |
| Accounts payable | (2) | (1,068) |
| Accrued expenses | (1,321) | (652) |
| Accrued income taxes | 687 | (107) |
| Deferred revenue | (673) | 1,368 |
| Other current liabilities | 34 | 830 |
| Other long-term liabilities | (9) | (417) |
| Net cash (used in) provided by operating activities | (8,794) | 2,166 |
| Cash flows from investing activities: | ||
| Purchases of marketable securities | (67,809) | — |
| Purchases of property and equipment | (56) | (202) |
| Net cash used in investing activities | (67,865) | (202) |
| Cash flows from financing activities: | ||
| Proceeds from initial public offering, net of underwriting fees | 106,020 | — |
| Proceeds from issuance of convertible note, net of debt issuance costs | 4,852 | — |
| Proceeds from loan facility | 4,250 | — |
| Repayment of loan facility | (4,250) | — |
| Repayment of 2022 line of credit | (2,000) | — |
| Deferred transaction costs | (2,126) | — |
| Contingent consideration | (22) | (921) |
| Payments of vendor financing obligation | (300) | — |
| Net cash provided by (used in) financing activities | 106,424 | (921) |
| Effect of exchange rate fluctuations on cash and cash equivalents | 88 | (173) |
| Net increase in cash and cash equivalents | 29,853 | 870 |
| Cash and cash equivalents, beginning of period | 4,421 | 5,478 |
| Cash and cash equivalents, end of period | $34,274 | $6,348 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.